In last trading session, Dare Bioscience Inc (NASDAQ:DARE) saw 0.33 million shares changing hands with its beta currently measuring 1.29. Company’s recent per share price level of $0.31 trading at $0.0 or -0.26% at ring of the bell on the day assigns it a market valuation of $31.30M. That closing price of DARE’s stock is at a discount of -241.94% from its 52-week high price of $1.06 and is indicating a premium of 12.9% from its 52-week low price of $0.27. Taking a look at company’s average trading volume volume of 669.93K if we extend that period to 3-months.
Dare Bioscience Inc (NASDAQ:DARE) trade information
Upright in the red during last session for losing -0.26%, in the last five days DARE remained trading in the green while hitting it’s week-highest on Tuesday, 04/30/24 when the stock touched $0.31 price level, adding 20.59% to its value on the day. Dare Bioscience Inc’s shares saw a change of 0.71% in year-to-date performance and have moved 1.73% in past 5-day. Dare Bioscience Inc (NASDAQ:DARE) showed a performance of -38.86% in past 30-days.
Dare Bioscience Inc (DARE) estimates and forecasts
Statistics highlight that Dare Bioscience Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -24.10% of value to its shares in past 6 months, showing an annual growth rate of 37.14% while that of industry is 12.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 456.30% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 260k for the same. And 2 analysts are in estimates of company making revenue of 13.03M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 26.02% during past 5 years.
DARE Dividends
Dare Bioscience Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
